2010
DOI: 10.1016/j.ijgo.2009.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Community‐based distribution of misoprostol for treatment or prevention of postpartum hemorrhage: Cost‐effectiveness, mortality, and morbidity reduction analysis

Abstract: Both interventions were more effective at decreasing mortality and anemia than standard management. The most efficient scale-up plan would focus initially on increasing coverage with the treatment strategy ($6 per DALY).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
41
0
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(43 citation statements)
references
References 22 publications
1
41
0
1
Order By: Relevance
“…In the Nepal study, there was a statistically significant decline in maternal mortality (98). Based on these and other data, the utilization of misoprostol for home births has the potential to reduce maternal mortality in these settings by 38-81% (121,122).…”
Section: Improvement Of Women's Healthmentioning
confidence: 82%
“…In the Nepal study, there was a statistically significant decline in maternal mortality (98). Based on these and other data, the utilization of misoprostol for home births has the potential to reduce maternal mortality in these settings by 38-81% (121,122).…”
Section: Improvement Of Women's Healthmentioning
confidence: 82%
“…If TBAs could be taken on board after training could avert some of these health problems especially maternal and new-born mortality. Interventions to reduce adverse outcomes in births attended by an TBAs and other unskilled birth attendants may include, provision of oral uterotonics (Sutherland et al, 2010;Prata et al, 2011) and/or clean delivery kits (Winani et al, 2007) to mothers or postnatal home visits (Bang et al,2oo5) to identify problems.…”
Section: The Role Of Tbas On Reproductive Healthmentioning
confidence: 99%
“…These devices are all low-cost and feasible to implement even in very low-income countries. These devices are likely to be at least as cost-effective as screening for pre-eclampsia using uterine artery Doppler and serum biomarkers [8], prophylactic magnesium sulfate for pre-eclampsia [9], community-based distribution of misoprostol for treatment or prevention of postpartum hemorrhage [23], screening for bacteriuria or syphilis, skilled birth attendance, management of obstructed labor, post-partum hemorrhage and maternal sepsis [24]. Furthermore, these devices are well within the range considered cost-effective in low-income countries based on the World Health Organization definition.…”
Section: Discussionmentioning
confidence: 99%